Rapid molecular detection of tuberculosis [4]

New England Journal of Medicine

Volumn 364, Issue 2, 2011, Pages 183-

  Andrea, Zbinden ^a   Keller, Peter M ^a   Bloemberg, Guido V ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN;

ANTIBIOTIC RESISTANCE; DIAGNOSTIC ERROR; HUMAN; LETTER; MOLECULAR DIAGNOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE; TUBERCULOSIS;

EID: 78651352390     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: None     Document Type: Letter

References (3)

1. Donald PR, van Helden PD. The global burden of tuberculosis - combating drug resistance in difficult times. N Engl J Med 2009;360:2393-5.
2. Sintchenko V, Jelfs PJ, Chew W, et al. Mycobacterium tuberculosis rpoB gene DNA sequencing: implications for detection of rifamycin resistance. J Antimicrob Chemother 1999;44:294-5.
3. Yang B, Koga H, Ohno H, et al. Relationship between anti-mycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis. J Antimicrob Chemother 1998;42:621-8. [Erratum, J Antimicrob Chemother 1999;43:613.]